Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis

被引:3
|
作者
Tsitsou-Kampeli, Afroditi [1 ]
Suzzi, Stefano [1 ,7 ]
Kenigsbuch, Mor [1 ,2 ]
Satomi, Akisawa [1 ,3 ]
Strobelt, Romano [4 ]
Singer, Oded [5 ]
Feldmesser, Ester [5 ]
Purnapatre, Maitreyee
Colaiuta, Sarah Phoebeluc [1 ]
David, Eyal [2 ]
Cahalon, Liora [1 ]
Hahn, Oliver [6 ]
Wyss-Coray, Tony [6 ]
Shaul, Yosef
Amit, Ido
Schwartz, Michal [1 ]
机构
[1] Weizmann Inst Sci, Dept Brain Sci, Rehovot, Israel
[2] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan
[4] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel
[5] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel
[6] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA USA
[7] Univ Paris Cite, Percept & Act Unit, Inst Pasteur, CNRS UMR3571, F-75015 Paris, France
基金
欧洲研究理事会; 以色列科学基金会;
关键词
NF-KAPPA-B; ALZHEIMERS-DISEASE; CYTOCHROME-P450; 46A1; GENE-EXPRESSION; RECEPTOR LXR; ENZYME; CELLS; MICE; OXYSTEROLS; REVEALS;
D O I
10.1016/j.xcrm.2023.101278
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The choroid plexus (CP) plays a key role in remotely controlling brain function in health, aging, and disease. Here, we report that CP epithelial cells express the brain-specific cholesterol 24-hydroxylase (CYP46A1) and that its levels are decreased under different mouse and human brain conditions, including amyloidosis, ag-ing, and SARS-CoV-2 infection. Using primary mouse CP cell cultures, we demonstrate that the enzymatic product of CYP46A1, 24(S)-hydroxycholesterol, downregulates inflammatory transcriptomic signatures within the CP, found here to be elevated across multiple neurological conditions. In vitro, the pro -inflamma-tory cytokine tumor necrosis factor a (TNF-a) downregulates CYP46A1 expression, while overexpression of CYP46A1 or its pharmacological activation in mouse CP organ cultures increases resilience to TNF-a. In vivo, overexpression of CYP46A1 in the CP in transgenic mice with amyloidosis is associated with better cognitive performance and decreased brain inflammation. Our findings suggest that CYP46A1 expression in the CP im-pacts the role of this niche as a guardian of brain immune homeostasis.
引用
收藏
页数:24
相关论文
共 50 条
  • [41] Development of a Novel 18F-Labeled Radioligand for Imaging Cholesterol 24-Hydroxylase with Positron Emission Tomography
    Rong, Jian
    Zhao, Chunyu
    Chaudhary, Ahmad F.
    Chen, Jiahui
    Zhou, Xin
    Zhang, Kuo
    Song, Zhendong
    Sun, Zhenkun
    Gao, Yabiao
    Zhang, Zachary
    Feng, Siyan
    Collier, Thomas Lee
    Yuan, Hongjie
    Patel, Jimmy S.
    Haider, Achi
    Li, Yinlong
    Liang, Steven H.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2025, 8 (03) : 800 - 807
  • [42] Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease
    Ingelsson, M
    Jesneck, J
    Irizarry, MC
    Hyman, BT
    Rebeck, GW
    NEUROSCIENCE LETTERS, 2004, 367 (02) : 228 - 231
  • [43] Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24-hydroxylase inhibitor soticlestat in healthy volunteers
    Yin, Wei
    Ballard, T. Eric
    Zhu, Sean Xiaochun
    Hsiao, Samuel
    Chen, Hao
    Li, Yuexian
    Chowdhury, Swapan K.
    Stevenson, Annette
    Hui, Tom
    Hunt, Allen
    Asgharnejad, Mahnaz
    Han, Steve
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (02) : 516 - 527
  • [44] Inhibition of Cholesterol 24-Hydroxylase Improves the Survival of a Mouse Model of Epileptic Phenotype and Modulates Extracellular Levels of Glutamate
    Nishi, Toshiya
    Watanabe, Sayuri
    Hasegawa, Shigeo
    Fujimoto, Shinji
    Sunahara, Eiji
    Ohori, Momoko
    Koike, Tatsuki
    Miyamoto, Maki
    Kondo, Shinichi
    Koike, Tatsuki
    Miyamoto, Maki
    Kondo, Shinichi
    NEUROTHERAPEUTICS, 2019, 16 (03) : 914 - 914
  • [45] AAV Gene Therapy with Cholesterol 24-Hydroxylase Reverses Alzheimer Phenotype of APP23 Mouse Model
    Hudry, Eloise
    Van Dam, Debby
    Kulik, Wim
    De Deyn, Peter P.
    Stet, Femke F.
    Ahouansou, Ornella
    Benraiss, Abdellatif
    Delacourte, Andre
    Bougneres, Pierre
    Aubourg, Patrick
    Cartier, Nathalie
    MOLECULAR THERAPY, 2009, 17 : S148 - S148
  • [46] Population pharmacokinetics, enzyme occupancy, and 24S-hydroxycholesterol modeling of soticlestat, a novel cholesterol 24-hydroxylase inhibitor, in healthy adults
    Yin, Wei
    Facius, Axel
    Wagner, Thomas
    Tsai, Max
    Asgharnejad, Mahnaz
    Lahu, Gezim
    Vakilynejad, Majid
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (07): : 1149 - 1162
  • [47] Development of a Novel 18F-Labeled Radioligand for Imaging Cholesterol 24-Hydroxylase with Positron Emission Tomography
    Rong, Jian
    Zhao, Chunyu
    Chaudhary, Ahmad F.
    Chen, Jiahui
    Zhou, Xin
    Zhang, Kuo
    Song, Zhendong
    Sun, Zhenkun
    Gao, Yabiao
    Zhang, Zachary
    Feng, Siyan
    Collier, Thomas Lee
    Yuan, Hongjie
    Patel, Jimmy S.
    Haider, Achi
    Li, Yinlong
    Liang, Steven H.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2025,
  • [48] Putative linkage of FGF2 with AVP in brain fluid homeostasis: role of the choroid plexus
    Johanson, CE
    Baird, A
    Duncan, JA
    Stopa, EG
    Gonzalez, AM
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 61 - 61
  • [49] Design and synthesis of aryl-piperidine derivatives as potent and selective PET tracers for cholesterol 24-hydroxylase (CH24H)
    Ikeda, Shuhei
    Kajita, Yuichi
    Miyamoto, Maki
    Matsumiya, Kouta
    Ishii, Tsuyoshi
    Nishi, Toshiya
    Gay, Sean C.
    Lane, Weston
    Constantinescu, Cristian C.
    Alagille, David
    Papin, Caroline
    Tamagnan, Gilles
    Kuroita, Takanobu
    Koike, Tatsuki
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [50] Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase
    Koike, Tatsuki
    Constantinescu, Cristian C.
    Ikeda, Shuhei
    Nishi, Toshiya
    Sunahara, Eiji
    Miyamoto, Maki
    Cole, Patricia
    Barret, Olivier
    Alagille, David
    Papin, Caroline
    Morley, Thomas
    Fowles, Krista
    Seibyl, John
    Tamagnan, Gilles
    Kuroita, Takanobu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (04) : 1148 - 1156